These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 19264746)

  • 1. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preserved residual renal function is associated with lower oxidative stress in peritoneal dialysis patients.
    Ignace S; Fouque D; Arkouche W; Steghens JP; Guebre-Egziabher F
    Nephrol Dial Transplant; 2009 May; 24(5):1685-9. PubMed ID: 19276104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress markers and C-reactive protein in pediatric patients on hemodialysis.
    Elshamaa MF; Sabry S; Nabih M; Elghoroury EA; El-Saaid GS; Ismail AA
    Ann Nutr Metab; 2009; 55(4):309-16. PubMed ID: 19828941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatible dialysis membranes and oxidative stress in patients wih end-stage renal disease on maintenance haemodialysis.
    Abdel-Naeem NM; Kandell NF; El-Shamaa AA; Harba TM; Abdel-Hady AA
    J Egypt Soc Parasitol; 2005 Dec; 35(3 Suppl):1173-97. PubMed ID: 16363293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of trimetazidine on lipid peroxidation in patients with end-stage renal disease.
    Aygen B; Celiker H; Dogukan A; Ilhan N
    Methods Find Exp Clin Pharmacol; 2008 Dec; 30(10):757-60. PubMed ID: 19271025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethylarginines in complicated type 1 diabetes: roles of insulin, glucose, and oxidative stress.
    Cighetti G; Fermo I; Aman CS; Ferraroni M; Secchi A; Fiorina P; Paroni R
    Free Radic Biol Med; 2009 Aug; 47(3):307-11. PubMed ID: 19446631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated circulating levels of soluble CD-40 ligand in haemodialysis patients with symptomatic coronary heart disease.
    Lim PS; Wu MY; Chien SW; Wu TK; Liu CS; Hu CY; Chang HC; Pai MA
    Nephrology (Carlton); 2008 Dec; 13(8):677-83. PubMed ID: 19019166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronegative LDL and lipid abnormalities in patients undergoing hemodialysis and peritoneal dialysis.
    Lobo J; Santos F; Grosso D; Lima R; Barreira AL; Leite M; Mafra D; Abdalla DS
    Nephron Clin Pract; 2008; 108(4):c298-304. PubMed ID: 18434752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients.
    Cavdar C; Temiz A; Yeniçerioğlu Y; Calişkan S; Celik A; Sifil A; Onvural B; Camsari T
    Scand J Urol Nephrol; 2003; 37(1):77-82. PubMed ID: 12745750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of vitamin E therapy on oxidative stress and erythrocyte osmotic fragility in patients on peritoneal dialysis and hemodialysis.
    Uzum A; Toprak O; Gumustas MK; Ciftci S; Sen S
    J Nephrol; 2006; 19(6):739-45. PubMed ID: 17173246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in elderly chronic renal failure patients: effects of renal replacement therapies on cell membrane fluidity.
    Goi G; Massaccesi L; Baquero Herrera CJ; Musetti C; Ciurlino D; Cusi D; Bertoli S
    J Nephrol; 2009; 22(5):630-6. PubMed ID: 19809996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma free amino acids and their metabolites in Taiwanese patients on hemodialysis and continuous ambulatory peritoneal dialysis.
    Chuang CK; Lin SP; Chen HH; Chen YC; Wang TJ; Shieh WH; Wu CJ
    Clin Chim Acta; 2006 Feb; 364(1-2):209-16. PubMed ID: 16087168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of plasma total F2-isoprostanes before and after hemodialysis in end-stage renal disease patients.
    Kim KM; Jung BH; Paeng KJ; Kim SW; Chung BC
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):475-8. PubMed ID: 15062851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ghrelin levels in patients undergoing haemodialysis and peritoneal dialysis.
    Pérez-Fontán M; Cordido F; Rodríguez-Carmona A; Peteiro J; García-Naveiro R; García-Buela J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2095-100. PubMed ID: 15187192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis.
    Lucchi L; Iannone A; Bergamini S; Stipo L; Perrone S; Uggeri S; Gatti V; Ferrari F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Oct; 29(10):832-7. PubMed ID: 16185346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does treatment of renal anemia with recombinant erythropoietin influence oxidative stress in hemodialysis patients?
    Sommerburg O; Grune T; Hampl H; Riedel E; Ehrich JH; Siems WG
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S23-9. PubMed ID: 10746802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.